lysophosphatidic acid has been researched along with EBV Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawson, CW; Ibrahim, MH; Khoo, AS; Lee, HM; Murray, PG; Paterson, IC; Rajadurai, P; Taylor, GS; Thavaraj, S; Tsao, SW; Velapasamy, S; Vrzalikova, K; Wei, W; Yap, LF | 1 |
Aoki, J; Arai, H; Baumforth, KR; Davies, G; Flavell, JR; Kishi, Y; Morgan, S; Murray, PG; Nowakova, M; Pettit, TR; Pratt, G; Reynolds, GM; Stankovic, T; Wakelam, MJ; Wei, W; Young, LS | 1 |
2 other study(ies) available for lysophosphatidic acid and EBV Infections
Article | Year |
---|---|
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.
Topics: Adenocarcinoma; Carcinoma; Cell Line, Tumor; Cell Movement; Down-Regulation; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lysophospholipids; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; T-Lymphocytes, Cytotoxic; Viral Matrix Proteins | 2015 |
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Glucose-6-Phosphate Isomerase; Glycoproteins; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lysophospholipids; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Up-Regulation | 2005 |